Skip to main content
. 2009 Aug 14;4(8):e6649. doi: 10.1371/journal.pone.0006649

Figure 5. Glucose turnover rate during euglycemic-hyperinsulinemic clamps.

Figure 5

Glucose Utilization and Hepatic Glucose Production during euglycemic-hyperinsulinemic clamp (0.4 U·kg−1·h−1) in Control and IL rats before and after L-NMMA (A), 7-Ni (B). L-Arginine (C) or SNP (E) carotid injection. L-NMMA: non selective NOS inhibitor. 7-Ni: selective neuronal NOS inhibitor. W1400: selective inflammatory NOS inhibitor. SNP: chemical NO donor. Values are means±SEM in each group. * p<0.01 vs C rats.